Hematology and Oncology (Cancer) | More
Professor of Medicine Director, Hematologic Malignancies Program
UChicago Medicine Open for more information
A clinically integrated network of physicians and providers employed by UChicago Medicine who offer care in inpatient, community, ambulatory, acute care or extended care settings.
Close
Richard A. Larson, MD, is director of the Hematologic Malignancies Clinical Research Program at the University of Chicago. He was the director of the Leukemia Clinical Research Program from 1983 to 2000, during which time he established the medical center's allogeneic blood and marrow transplant program.
Dr. Larson maintains an active clinical practice at the University of Chicago Medicine, and his expertise is widely sought for consultations regarding leukemias and myelodysplastic syndromes.
His current research interests include clinical trials in hematologic malignancies and stem cell transplantation, experimental therapeutics, the determinants of response to therapy in leukemia and myelodysplastic syndromes, and the etiology of therapy-related leukemias.
Dr. Larson is the past chairman of the Leukemia Committee of the Cancer and Leukemia Group B where he directed a large portfolio of clinical trials and ancillary laboratory studies in acute and chronic leukemias. He has also served as a member of the Hematology Subspecialty Board of the American Board of Internal Medicine.
An active researcher, Dr. Larson has published more than 400 papers, reviews, and book chapters on clinical and laboratory studies in human leukemias. He has served on the editorial boards of BLOOD, the Journal of Clinical Oncology and Leukemia.
He also actively participates in the training of 21 fellows in Hematology/Oncology within the Department of Medicine.
Dr. Larson maintains an active clinical practice at the University of Chicago Medicine, and his expertise is widely sought for consultations regarding leukemias and myelodysplastic syndromes.
His current research interests include clinical trials in hematologic malignancies and stem cell transplantation, experimental therapeutics, the determinants of response to therapy in leukemia and myelodysplastic syndromes, and the etiology of therapy-related leukemias.
Dr. Larson is the past chairman of the Leukemia Committee of the Cancer and Leukemia Group B where he directed a large portfolio of clinical trials and ancillary laboratory studies in acute and chronic leukemias. He has also served as a member of the Hematology Subspecialty Board of the American Board of Internal Medicine.
An active researcher, Dr. Larson has published more than 400 papers, reviews, and book chapters on clinical and laboratory studies in human leukemias. He has served on the editorial boards of BLOOD, the Journal of Clinical Oncology and Leukemia.
He also actively participates in the training of 21 fellows in Hematology/Oncology within the Department of Medicine.
Specialties
Areas of Expertise
Medical Education
- Stanford University School of Medicine
Internship
- University of Chicago Medicine
Residency
- University of Chicago Medicine
Memberships & Medical Societies
- American Society of Clinical Oncology
- American Association for Cancer Research
- American Society of Hematology
- Aetna POS
- Aetna HMO
- Aetna PPO
- BCBS Blue Precision HMO
- BCBS HMO (HMOI)
- BCBS PPO
- Cigna HMO
- Cigna POS
- Cigna PPO
- CountyCare
- Coventry Health Plan PPO
- Great West PPO
- Illinicare*
- Medicare
- Multiplan PPO
- PHCS PPO
- United Choice / Choice Plus
- United Options (PPO)
- United Select (HMO & EPO)
- United W500 Emergent Wrap
To Request an Appointment
Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
Request an Appointment at Duchossois Center for Advanced Medicine (DCAM) - Hyde Park
To Refer a Patient
Refer a Patient